Skip to content

Compare the analgesic efficacy and safety of suprascapular nerve block combined with superficial cervical plexus block and intermuscular sulcus brachial plexus block for arthroscopic rotator cuff repair

Comparison of the efficacy of suprascapular nerve block combined with superficial cervical plexus block versus interscalene brachial plexus block in arthroscopic rotator cuff repair

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127562
Enrollment
Unknown
Registered
2026-07-02
Start date
2021-01-06
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve block protocols for arthroscopic rotator cuff repair

Interventions

Interscalene Brachial Plexus Block Group (ISB Group):Patients in this group received 15 mL of 0.5% ropivacaine for interscalene brachial plexus block.
Suprascapular Nerve Block Group (Group SNB-SCB ?):Patients in this group underwent suprascapular nerve block with 5 mL of 0.5% ropivacaine and superficial cervical plexus block with 10 mL of 0.5% ropi
Suprascapular Nerve Block Group (Group SNB-SCB II):Patients in this group underwent suprascapular nerve block with 7.5 mL of 0.5% ropivacaine and superficial cervical plexus block with 7.5 mL of 0.5%
Suprascapular Nerve Block Group (Group SNB-SCB III):Patients in this group underwent suprascapular nerve block with 10 mL of 0.5% ropivacaine and superficial cervical plexus block with 5 mL of 0.5% r

Sponsors

Tenth People’s Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for arthroscopic rotator cuff repair in Shanghai Tenth People’s Hospital, aged >= 18 years, ASA grade I–III, without contraindications to nerve block.

Exclusion criteria

Exclusion criteria: Patients with contraindications to nerve block, severe contralateral pulmonary insufficiency, severe hearing or visual impairment, and inability to cooperate with examinations.

Design outcomes

Primary

MeasureTime frame
Pain score;Biceps brachii strength;Shoulder abduction Angle;Grip strength;

Secondary

MeasureTime frame
Patient satisfaction;The need for remedial analgesia;

Countries

China

Contacts

Public ContactLingling Zhang

Tenth People’s Hospital of Tongji University

15317005862@163.com+86 21 6630 7050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026